News
Revumenib abstracts highlight compelling results in acute leukemia across the frontline and R/R setting and multiple genetic populations, including mNPM1, KMT2Ar, and NUP98r – – Axatilimab abstracts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback